LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia

Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive...

Full description

Saved in:
Bibliographic Details
Published inBrain and behavior Vol. 12; no. 2; pp. e2466 - n/a
Main Authors Li, Meng‐lin, Peng, Yuan, An, Ying, Li, Guo‐yan, Lan, Yue
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.02.2022
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text
ISSN2162-3279
2162-3279
DOI10.1002/brb3.2466

Cover

Abstract Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear. Materials and methods Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP‐response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting. Results In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model. Conclusions Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.
AbstractList IntroductionSynaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear.Materials and methodsJuvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP-response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting.ResultsIn the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model.ConclusionsOur investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.
Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.
Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear. Materials and methods Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP‐response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting. Results In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model. Conclusions Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ. Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.
Synaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear.INTRODUCTIONSynaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear.Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP-response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting.MATERIALS AND METHODSJuvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP-response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting.In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model.RESULTSIn the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model.Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.CONCLUSIONSOur investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.
Synaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear. Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP-response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting. In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model. Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.
Abstract Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM) model of schizophrenia (SCZ). Recent research has shown that LY395756 can effectively restore NR2B levels and improve cognitive performance in juvenile MAM mice model. However, the underlying mechanisms of these beneficial effects remain unclear. Materials and methods Juvenile MAM mice model of SCZ is used in our study. Synaptic membrane protein levels were examined by western blotting under different treatment conditions. Interaction of cAMP‐response element binding protein (CREB) and the promoter of NR2B was detected by the chromatin immunoprecipitation (ChIP) assay. Further examination of signaling pathway that mediates NR2B expression was also investigated by western blotting. Results In the PFC of the juvenile MAM mice schizophrenia model, CREB was found to directly bind with the promoter of NR2B. LY395756 activated the phosphorylation of AKT. Phosphorylated AKT subsequently induced the phosphorylation of CREB, and the activated CREB promoted the expression of NR2B. Subsequent experiments showed that the dephosphorylation of CREB induced by protein phosphatase 1 (PP1) can inhibit NR2B levels. Taken together, these findings support that the AKT/CREB signaling pathway is essential for the promoting effect of LY395756 on synaptic NR2B in PFC in juvenile MAM mice SCZ model. Conclusions Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway warrants further research as a potential direction for clinical treatment of SCZ.
Author Li, Guo‐yan
Lan, Yue
Peng, Yuan
An, Ying
Li, Meng‐lin
AuthorAffiliation 1 Department of Rehabilitation Guangzhou First People's Hospital School of Medicine South China University of Technology Guangzhou China
AuthorAffiliation_xml – name: 1 Department of Rehabilitation Guangzhou First People's Hospital School of Medicine South China University of Technology Guangzhou China
Author_xml – sequence: 1
  givenname: Meng‐lin
  surname: Li
  fullname: Li, Meng‐lin
  organization: South China University of Technology
– sequence: 2
  givenname: Yuan
  surname: Peng
  fullname: Peng, Yuan
  organization: South China University of Technology
– sequence: 3
  givenname: Ying
  surname: An
  fullname: An, Ying
  organization: South China University of Technology
– sequence: 4
  givenname: Guo‐yan
  surname: Li
  fullname: Li, Guo‐yan
  organization: South China University of Technology
– sequence: 5
  givenname: Yue
  surname: Lan
  fullname: Lan, Yue
  email: bluemooning@163.com
  organization: South China University of Technology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35025141$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9uEzEQxleoiJbSAy-ALHGBQxr_390LUhMVqIhAisqBk-XdnU0cee1gb0LTB-C58SYtaivwxTOe7_tpbM_L7Mh5B1n2muBzgjEdV6Fi55RL-Sw7oUTSEaN5efQgPs7OYlzhtAThlOMX2TETmKaEnGS_Zz9YKXIh0Tr4zvcQ0dc5nSC4WQeI0XiHtkYjXfdmq_sh9S26-HI9ns4vJyiahdPWuAUyDvVLQKvNFpyxgDrolzurb_3Nbgi18xZ1pk4F34AdILFemlu_XoZk0K-y5622Ec7u9tPs-8fL6-nn0ezbp6vpxWxUC1zKUbpTzvIWC0Z4XpdSUMxrKTUVLZVStgRY03BaUl2ClEWFAUiKC8K4xLrR7DS7OnAbr1dqHUynw055bdT-wIeF0qE3tQWlaUNxU1R5wwTXgpdlVUEODZWF5FTTxPpwYK03VQdNDa4P2j6CPq44s1QLv1VFIQUROAHe3QGC_7mB2KvOxBqs1Q78JioqSSk4JyxP0rdPpCu_CentBxUjRVESyZLqzcOO_rZy_91JMD4I6uBjDNCq2vT7b00NGqsIVsNMqWGm1DBTyfH-ieMe-i_tHf1XmoDd_4VqMp-wveMPFJfZgg
CitedBy_id crossref_primary_10_1038_s41380_023_02065_4
crossref_primary_10_3389_fnins_2022_974940
crossref_primary_10_1016_j_expneurol_2022_114299
crossref_primary_10_2174_1570159X22666240206111838
crossref_primary_10_3390_biomedicines12051097
crossref_primary_10_1042_NS20210058
Cites_doi 10.1093/schbul/sbp006
10.1038/sj.npp.1301604
10.1016/j.pnpbp.2015.02.012
10.1016/j.psychres.2019.112497
10.2174/1566523218666180302163029
10.1016/j.neuropharm.2007.05.018
10.1038/nrn3504
10.1016/j.nlm.2017.02.004
10.18632/oncotarget.7721
10.1371/journal.pone.0061787
10.1016/j.neuropharm.2011.06.007
10.1038/nature00928
10.2741/2190
10.1016/j.bbrc.2010.12.048
10.1016/j.tips.2008.10.006
10.1016/j.neuropharm.2018.05.019
10.1016/s0165‐0173(99)00044‐2
10.21037/apm-21-472
10.1017/s1461145713000928
10.1007/s00213‐016‐4230‐0
10.1016/j.mcn.2014.04.002
10.1016/s0140‐6736(09)60995‐8
10.1097/00001756‐200109170‐00043
10.1038/35085068
10.1016/j.bbr.2016.11.053
10.1016/j.pbb.2006.05.021
10.1111/j.1601‐183X.2009.00474.x
10.1038/npp.2012.180
10.1016/j.tins.2017.10.002
10.1038/nature09552
10.1126/stke.2001.94.pe1
10.1016/j.tins.2005.06.005
10.1186/s12888‐021‐03384‐y
10.1038/nm1632
10.1016/j.expneurol.2015.08.019
10.1074/jbc.273.49.32377
10.1126/science.281.5381.1349
10.1016/j.jad.2013.09.033
10.1007/s00403‐018‐1816‐x
10.1016/j.schres.2006.02.001
10.1007/s12011‐015‐0478‐1
10.1523/jneurosci.0792‐06.2006
10.1016/j.euroneuro.2017.03.005
10.1038/sj.mp.4001556
10.1016/j.neubiorev.2016.05.030
10.1111/jnc.14101
ContentType Journal Article
Copyright 2022 The Authors. published by Wiley Periodicals LLC
2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by Wiley Periodicals LLC
– notice: 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
– notice: 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88G
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M2M
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.1002/brb3.2466
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Psychology Database
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Open Access Journals
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate LI et al
EISSN 2162-3279
EndPage n/a
ExternalDocumentID oai_doaj_org_article_a2d20d8b7d354a5499bbe7ed268642a2
PMC8865150
35025141
10_1002_brb3_2466
BRB32466
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Beijing China
United States--US
China
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GrantInformation_xml – fundername: National Natural Science Foundation of China
  funderid: 81701318
– fundername: ;
  grantid: 81701318
GroupedDBID 0R~
1OC
24P
53G
5VS
7X7
8-0
8-1
8FI
8FJ
8G5
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACCMX
ACGFO
ACUHS
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AFKRA
AHMBA
AIAGR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
D-8
D-9
DIK
DWQXO
EBS
EJD
ESX
FYUFA
GNUQQ
GODZA
GROUPED_DOAJ
GUQSH
GX1
HMCUK
HYE
IAO
IHR
ITC
KQ8
M2M
M2O
M48
M~E
OK1
PIMPY
PQQKQ
PROAC
PSYQQ
RNS
RPM
SUPJJ
TUS
UKHRP
WIN
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c5096-216737f053147c965204c66a25f2666f1e3dd4292a9e668b0ee12a9813460ada3
IEDL.DBID 7X7
ISSN 2162-3279
IngestDate Wed Aug 27 01:25:07 EDT 2025
Thu Aug 21 18:34:14 EDT 2025
Fri Sep 05 11:45:52 EDT 2025
Sun Jul 13 04:52:19 EDT 2025
Wed Feb 19 02:26:24 EST 2025
Tue Jul 01 02:08:42 EDT 2025
Thu Apr 24 23:09:44 EDT 2025
Wed Jan 22 16:27:05 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords NR2B
LY395756
CREB
schizophrenia
Language English
License Attribution
2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5096-216737f053147c965204c66a25f2666f1e3dd4292a9e668b0ee12a9813460ada3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2631889163?pq-origsite=%requestingapplication%
PMID 35025141
PQID 2631889163
PQPubID 976341
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_a2d20d8b7d354a5499bbe7ed268642a2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8865150
proquest_miscellaneous_2619544137
proquest_journals_2631889163
pubmed_primary_35025141
crossref_citationtrail_10_1002_brb3_2466
crossref_primary_10_1002_brb3_2466
wiley_primary_10_1002_brb3_2466_BRB32466
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2022
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: February 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Los Angeles
– name: Hoboken
PublicationTitle Brain and behavior
PublicationTitleAlternate Brain Behav
PublicationYear 2022
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2017; 40
2010; 11
1998; 281
2021; 21
2010; 468
2017; 27
2009
2009; 374
2002; 418
2008; 33
2016; 70
2007; 53
2013; 8
2005; 28
2007; 12
2014; 60
2007; 13
1998; 273
2015; 273
2018; 18
2009; 35
2016; 7
2009; 30
2021; 10
2019; 280
2013; 14
2011; 404
2006; 84
2013; 16
2013; 38
2015; 60
2018; 310
2018; 137
2006; 26
2000; 31
2016; 233
2014; 152‐154
2005; 10
2009; 8
2017; 140
2001; 2
2017; 143
2001; 12
2016; 170
2001; 2001
2017; 325
2012; 62
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_47_1
e_1_2_7_26_1
e_1_2_7_48_1
e_1_2_7_27_1
e_1_2_7_49_1
e_1_2_7_28_1
e_1_2_7_29_1
Petralia R. S. (e_1_2_7_40_1) 2009
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_37_1
e_1_2_7_38_1
e_1_2_7_39_1
Mezler M. (e_1_2_7_32_1) 2010; 11
References_xml – volume: 280
  year: 2019
  article-title: PKA‐mediated phosphorylation of CREB and NMDA receptor 2B in the hippocampus of offspring rats is involved in transmission of mental disorders across a generation
  publication-title: Psychiatry Research
– volume: 18
  start-page: 45
  issue: 1
  year: 2018
  end-page: 63
  article-title: Dysfunction in brain‐derived neurotrophic factor signaling pathway and susceptibility to schizophrenia, Parkinson's and Alzheimer's diseases
  publication-title: Current Gene Therapy
– year: 2009
– volume: 84
  start-page: 392
  issue: 3
  year: 2006
  end-page: 399
  article-title: Effects of the mGluR2/3 agonist LY379268 on ketamine‐evoked behaviours and neurochemical changes in the dentate gyrus of the rat
  publication-title: Pharmacology, Biochemistry and Behavior
– volume: 60
  start-page: 66
  year: 2015
  end-page: 76
  article-title: Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?
  publication-title: Progress in Neuro‐Psychopharmacology & Biological Psychiatry
– volume: 33
  start-page: 2175
  issue: 9
  year: 2008
  end-page: 2186
  article-title: Lamina‐specific abnormalities of NMDA receptor‐associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder
  publication-title: Neuropsychopharmacology
– volume: 404
  start-page: 711
  issue: 2
  year: 2011
  end-page: 716
  article-title: CREB is a regulatory target for the protein kinase Akt/PKB in the differentiation of pancreatic ductal cells into islet β‐cells mediated by hepatocyte growth factor
  publication-title: Biochemical and Biophysical Research Communications
– volume: 152‐154
  start-page: 326
  year: 2014
  end-page: 333
  article-title: Alteration of cyclic‐AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia
  publication-title: Journal of Affective Disorders
– volume: 16
  start-page: 2181
  issue: 10
  year: 2013
  end-page: 2194
  article-title: Translating the N‐methyl‐D‐aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia
  publication-title: The International Journal of Neuropsychopharmacology
– volume: 21
  start-page: 373
  issue: 1
  year: 2021
  article-title: Understanding factors relevant to poor sleep and coping methods in people with schizophrenia
  publication-title: BMC Psychiatry
– volume: 27
  start-page: 470
  issue: 5
  year: 2017
  end-page: 483
  article-title: The involvement of BDNF‐CREB signaling pathways in the pharmacological mechanism of combined SSRI‐ antipsychotic treatment in schizophrenia
  publication-title: European Neuropsychopharmacology
– volume: 35
  start-page: 549
  issue: 3
  year: 2009
  end-page: 562
  article-title: The dopamine hypothesis of schizophrenia: Version III—the final common pathway
  publication-title: Schizophrenia Bulletin
– volume: 40
  start-page: 720
  issue: 12
  year: 2017
  end-page: 733
  article-title: Emerging roles of CREB‐regulated transcription coactivators in brain physiology and pathology
  publication-title: Trends in Neuroscience
– volume: 374
  start-page: 635
  issue: 9690
  year: 2009
  end-page: 645
  article-title: Schizophrenia
  publication-title: Lancet
– volume: 8
  issue: 4
  year: 2013
  article-title: Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons
  publication-title: PLoS One
– volume: 2
  start-page: 599
  issue: 8
  year: 2001
  end-page: 609
  article-title: Transcriptional regulation by the phosphorylation‐dependent factor CREB
  publication-title: Nature Reviews Molecular Cell Biology
– volume: 26
  start-page: 4690
  issue: 17
  year: 2006
  end-page: 4700
  article-title: Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation‐dependent subunit trafficking
  publication-title: Journal of Neuroscience
– volume: 12
  start-page: 1814
  year: 2007
  end-page: 1832
  article-title: Multisite phosphorylation of the cAMP response element‐binding protein (CREB) by a diversity of protein kinases
  publication-title: Frontiers in Bioscience
– volume: 60
  start-page: 63
  year: 2014
  end-page: 71
  article-title: Dynorphin up‐regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B‐containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathways
  publication-title: Molecular and Cellular Neuroscience
– volume: 137
  start-page: 359
  year: 2018
  end-page: 371
  article-title: Juvenile treatment with mGluR2/3 agonist prevents schizophrenia‐like phenotypes in adult by acting through GSK3β
  publication-title: Neuropharmacology
– volume: 70
  start-page: 260
  year: 2016
  end-page: 270
  article-title: Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model
  publication-title: Neuroscience and Biobehavioral Reviews
– volume: 281
  start-page: 1349
  issue: 5381
  year: 1998
  end-page: 1352
  article-title: Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
  publication-title: Science
– volume: 14
  start-page: 383
  issue: 6
  year: 2013
  end-page: 400
  article-title: NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease
  publication-title: Nature Reviews Neuroscience
– volume: 233
  start-page: 1349
  issue: 8
  year: 2016
  end-page: 1359
  article-title: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two‐hit mouse model of schizophrenia
  publication-title: Psychopharmacology
– volume: 143
  start-page: 320
  issue: 3
  year: 2017
  end-page: 333
  article-title: Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia
  publication-title: Journal of Neurochemistry
– volume: 325
  start-page: 79
  issue: Pt A
  year: 2017
  end-page: 86
  article-title: Autophagy and Akt/CREB signalling play an important role in the neuroprotective effect of nimodipine in a rat model of vascular dementia
  publication-title: Behavioural Brain Research
– volume: 13
  start-page: 1102
  issue: 9
  year: 2007
  end-page: 1107
  article-title: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
  publication-title: Nature Medicine
– volume: 30
  start-page: 25
  issue: 1
  year: 2009
  end-page: 31
  article-title: Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
  publication-title: Trends in Pharmacological Sciences
– volume: 8
  start-page: 320
  issue: 3
  year: 2009
  end-page: 329
  article-title: RNA interference in hippocampus demonstrates opposing roles for CREB and PP1alpha in contextual and temporal long‐term memory
  publication-title: Genes, Brain, and Behavior
– volume: 140
  start-page: 52
  year: 2017
  end-page: 61
  article-title: Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia
  publication-title: Neurobiology of Learning and Memory
– volume: 11
  start-page: 833
  issue: 7
  year: 2010
  end-page: 845
  article-title: LY‐2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY‐404039 for the potential treatment of schizophrenia
  publication-title: Current Opinion in Investigational Drugs
– volume: 273
  start-page: 190
  year: 2015
  end-page: 201
  article-title: LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801‐induced working memory impairment
  publication-title: Experimental Neurology
– volume: 10
  start-page: 4479
  issue: 4
  year: 2021
  end-page: 4485
  article-title: Poor sleep quality and its related risk factors among university students
  publication-title: Annals of Palliative Medicine
– volume: 170
  start-page: 366
  issue: 2
  year: 2016
  end-page: 372
  article-title: Role of PTEN‐Akt‐CREB signaling pathway in nervous system impairment of rats with chronic arsenite exposure
  publication-title: Biological Trace Element Research
– volume: 62
  start-page: 1473
  issue: 3
  year: 2012
  end-page: 1483
  article-title: Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia
  publication-title: Neuropharmacology
– volume: 10
  start-page: 79
  issue: 1
  year: 2005
  end-page: 104
  article-title: Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs
  publication-title: Molecular Psychiatry
– volume: 273
  start-page: 32377
  issue: 49
  year: 1998
  end-page: 32379
  article-title: CREB is a regulatory target for the protein kinase Akt/PKB
  publication-title: Journal of Biological Chemistry
– volume: 418
  start-page: 970
  issue: 6901
  year: 2002
  end-page: 975
  article-title: Protein phosphatase 1 is a molecular constraint on learning and memory
  publication-title: Nature
– volume: 310
  start-page: 187
  issue: 3
  year: 2018
  end-page: 196
  article-title: The stem cell factor‐stimulated melanogenesis in human melanocytes can be abrogated by interrupting the phosphorylation of MSK1: Evidence for involvement of the p38/MSK1/CREB/MITF axis
  publication-title: Archives of Dermatological Research
– volume: 468
  start-page: 187
  issue: 7321
  year: 2010
  end-page: 693
  article-title: Rethinking schizophrenia
  publication-title: Nature
– volume: 7
  start-page: 35454
  issue: 23
  year: 2016
  end-page: 35465
  article-title: Control of CREB expression in tumors: From molecular mechanisms and signal transduction pathways to therapeutic target
  publication-title: Oncotarget
– volume: 31
  start-page: 288
  issue: 2‐3
  year: 2000
  end-page: 294
  article-title: Glutamate receptor expression in schizophrenic brain
  publication-title: Brain Research Brain Research Reviews
– volume: 38
  start-page: 328
  issue: 2
  year: 2013
  end-page: 340
  article-title: Gestational methylazoxymethanol exposure leads to NMDAR dysfunction in hippocampus during early development and lasting deficits in learning
  publication-title: Neuropsychopharmacology
– volume: 12
  start-page: 2971
  issue: 13
  year: 2001
  end-page: 2974
  article-title: Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
  publication-title: NeuroReport
– volume: 28
  start-page: 436
  issue: 8
  year: 2005
  end-page: 445
  article-title: The many faces of CREB
  publication-title: Trends in Neuroscience
– volume: 2001
  issue: 94
  year: 2001
  article-title: New roles for introns: Sites of combinatorial regulation of Ca2+‐ and cyclic AMP‐dependent gene transcription
  publication-title: Science Signaling
– volume: 53
  start-page: 362
  issue: 3
  year: 2007
  end-page: 368
  article-title: Regulation of NMDA receptors by phosphorylation
  publication-title: Neuropharmacology
– volume: 84
  start-page: 214
  issue: 2–3
  year: 2006
  end-page: 221
  article-title: N‐methyl‐D‐aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels
  publication-title: Schizophrenia Research
– ident: e_1_2_7_16_1
  doi: 10.1093/schbul/sbp006
– ident: e_1_2_7_2_1
  doi: 10.1038/sj.npp.1301604
– volume: 11
  start-page: 833
  issue: 7
  year: 2010
  ident: e_1_2_7_32_1
  article-title: LY‐2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY‐404039 for the potential treatment of schizophrenia
  publication-title: Current Opinion in Investigational Drugs
– ident: e_1_2_7_24_1
  doi: 10.1016/j.pnpbp.2015.02.012
– ident: e_1_2_7_18_1
  doi: 10.1016/j.psychres.2019.112497
– ident: e_1_2_7_35_1
  doi: 10.2174/1566523218666180302163029
– ident: e_1_2_7_5_1
  doi: 10.1016/j.neuropharm.2007.05.018
– ident: e_1_2_7_37_1
  doi: 10.1038/nrn3504
– ident: e_1_2_7_23_1
  doi: 10.1016/j.nlm.2017.02.004
– ident: e_1_2_7_46_1
  doi: 10.18632/oncotarget.7721
– ident: e_1_2_7_48_1
  doi: 10.1371/journal.pone.0061787
– ident: e_1_2_7_10_1
  doi: 10.1016/j.neuropharm.2011.06.007
– ident: e_1_2_7_12_1
  doi: 10.1038/nature00928
– ident: e_1_2_7_21_1
  doi: 10.2741/2190
– ident: e_1_2_7_26_1
  doi: 10.1016/j.bbrc.2010.12.048
– ident: e_1_2_7_6_1
  doi: 10.1016/j.tips.2008.10.006
– ident: e_1_2_7_49_1
  doi: 10.1016/j.neuropharm.2018.05.019
– ident: e_1_2_7_30_1
  doi: 10.1016/s0165‐0173(99)00044‐2
– ident: e_1_2_7_27_1
  doi: 10.21037/apm-21-472
– ident: e_1_2_7_31_1
  doi: 10.1017/s1461145713000928
– ident: e_1_2_7_9_1
  doi: 10.1007/s00213‐016‐4230‐0
– ident: e_1_2_7_43_1
  doi: 10.1016/j.mcn.2014.04.002
– ident: e_1_2_7_47_1
  doi: 10.1016/s0140‐6736(09)60995‐8
– ident: e_1_2_7_22_1
  doi: 10.1097/00001756‐200109170‐00043
– ident: e_1_2_7_29_1
  doi: 10.1038/35085068
– ident: e_1_2_7_17_1
  doi: 10.1016/j.bbr.2016.11.053
– ident: e_1_2_7_19_1
  doi: 10.1016/j.pbb.2006.05.021
– ident: e_1_2_7_39_1
  doi: 10.1111/j.1601‐183X.2009.00474.x
– ident: e_1_2_7_45_1
  doi: 10.1038/npp.2012.180
– ident: e_1_2_7_44_1
  doi: 10.1016/j.tins.2017.10.002
– ident: e_1_2_7_20_1
  doi: 10.1038/nature09552
– ident: e_1_2_7_11_1
  doi: 10.1126/stke.2001.94.pe1
– volume-title: Biology of the NMDA receptor
  year: 2009
  ident: e_1_2_7_40_1
– ident: e_1_2_7_3_1
  doi: 10.1016/j.tins.2005.06.005
– ident: e_1_2_7_4_1
  doi: 10.1186/s12888‐021‐03384‐y
– ident: e_1_2_7_38_1
  doi: 10.1038/nm1632
– ident: e_1_2_7_25_1
  doi: 10.1016/j.expneurol.2015.08.019
– ident: e_1_2_7_7_1
  doi: 10.1074/jbc.273.49.32377
– ident: e_1_2_7_34_1
  doi: 10.1126/science.281.5381.1349
– ident: e_1_2_7_42_1
  doi: 10.1016/j.jad.2013.09.033
– ident: e_1_2_7_36_1
  doi: 10.1007/s00403‐018‐1816‐x
– ident: e_1_2_7_28_1
  doi: 10.1016/j.schres.2006.02.001
– ident: e_1_2_7_41_1
  doi: 10.1007/s12011‐015‐0478‐1
– ident: e_1_2_7_15_1
  doi: 10.1523/jneurosci.0792‐06.2006
– ident: e_1_2_7_8_1
  doi: 10.1016/j.euroneuro.2017.03.005
– ident: e_1_2_7_33_1
  doi: 10.1038/sj.mp.4001556
– ident: e_1_2_7_13_1
  doi: 10.1016/j.neubiorev.2016.05.030
– ident: e_1_2_7_14_1
  doi: 10.1111/jnc.14101
SSID ssj0000514240
Score 2.2693713
Snippet Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental...
Synaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental methylazoxymethanol (MAM)...
IntroductionSynaptic N-methyl-d-aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental...
Our investigation has identified a novel mechanism by which LY395756 increases NR2B expression in juvenile MAM mice SCZ model. The AKT/CREB signaling pathway...
Abstract Introduction Synaptic N‐methyl‐d‐aspartate receptor subtype 2B(NR2B) is significantly reduced in prefrontal cortex (PFC) in the neurodevelopmental...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e2466
SubjectTerms Amino Acids, Dicarboxylic
Animal cognition
Animals
Bridged Bicyclo Compounds
Cognitive ability
CREB
Cyclic AMP Response Element-Binding Protein - metabolism
Disease Models, Animal
Drug dosages
Fluorides
Laboratory animals
LY395756
Methylazoxymethanol Acetate - analogs & derivatives
Mice
NR2B
Original
Phosphorylation
Proteins
Proto-Oncogene Proteins c-akt - metabolism
Receptors, N-Methyl-D-Aspartate - metabolism
Schizophrenia
Schizophrenia - chemically induced
Signal Transduction
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwEB0hDohL1Q9K01LkIg69RJs4juMcGwRCVeGwAglOlh076larBLFsBf0B_d2dcbLLrqDqpTcrdizHHnue4_F7AIe1wHUx9T5unHGx4LyOy7JOYuI-z4SyvpdOODuXp5fi61V-tSL1RTFhPT1w33Ejwx1PnLKFy3JhaDdjrS-841IhdDZh9UU3trKZWrB6o69aUAklfGRvcdfIRWBDfHRAgaf_OXD5NEZyFbsG53PyEl4MqJF96Vv7CjZ8-xq2zoZz8Tfw-9s1nYTlkt2E8Do_Y-djXjF_P8S5tuznxDC6xND_gmVdwxDejY7GxxWjGA5D19LZpGUICNmPOS6B2A5G-tIPU_Oru3-gpGm7KSP9ehYEdKiS2WrQ3g5cnhxfHJ3Gg8JCXBPtS8xTkqlpaCKKoi5lzhNRS2l43qDjlk3qM-dI0MqUXkplE-9TTKs0EzIxzmRvYbPtWv8OmBJlrbAOyz2J_xZl0lhhZNrgq40seQSfF92u64F-nFQwpronTuaaRkjTCEVwsCx603NuPFeoorFbFiCa7PAAjUcPxqP_ZTwR7C1GXg9zd6a5xHVOIWzOIvi0zMZZR0cppvXdnMoQUx4CgCKC3d5Qli3Jctq3iTSCYs2E1pq6ntNOvgdmb6VImT7BvgrG9vev19W4yijx_n90wwfY5nSrIwSj78Hm3e3cf0SsdWf3w7T6A1LJJg8
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGkBAviPG1wIYMQoiXsMRxHOcBITJtmhDdQ0Wl8WQ5sQOdqqRrV9TyB_B3c-c4VSsKb1biWP64893F59-PkDcVh30xtjasjTYhZ6wK87yKQsQ-T7gsbUedMLgUFyP--Sq92iN9WrOfwPnO0A75pEazyfvlzeojKPwHDyB6Us4gIGRciLfTmxD5pPDc1ZNr3CF3wUYxlPeBd_x71G-wZT3U0GYjWwbK4fjvcj7_zqHc9G2dcTp_SB54r5J-6sTggOzZ5hG5N_Dn5o_J7y_f8KQsFXTq0u_snF4OWUHt0ufBNvTnWFO85ND9oqVtTcH9OzkdnhUUczw0Xlun44aCw0ivF7BFQj8o8k-vJvpXu1xhUTfthCK_PXUEO9jIfDOp7wkZnZ99Pb0IPQNDWCEsTMhipLGpUVF5VuUiZRGvhNAsrcGwizq2iTFIeKVzK4QsI2tjKMs44SLSRidPyX7TNvaQUMnzSkIbJbNIDpzlUV1yLeIaPq1FzgLyrp92VXl4cmTJmKgOWJkpXCGFKxSQ1-uq0w6TY1elAtduXQFhtN2DdvZdea1UmhkWGVlmJkm5xlC5LG1mDRMS4jINnTrqV171oqmYgH1QgludBOTV-jVoJR616Ma2C6yDSHrgIGQBedYJyronSYpxHY8Dkm2J0FZXt9804x8O-VtKZK6PYK6csP179KoYFgkWnv9_BC_IfYb3OVwa-hHZv50t7DF4WbflS6cwfwCtgia-
  priority: 102
  providerName: Scholars Portal
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELVKkRAXxDcpBRnEgUu0ydhxHHEiVasK0QqtqFROkR07ZdEqqXa7VcsP4Hcz42RDVxSJm5WMI8fjscf2zHuMvaslzoup93HjjIslQB0XRZ3EhH0upLa-p044OlaHJ_LTaXa6xT6sc2F6fIjxwI0sI8zXZODGLid_QEPtAreBIJW6w-6mtOoTrLP8Mh6wELA3hIRISBXEAvJijSyUwGSsvbEeBdj-23zNv0Mmb7qyYS06eMgeDE4k_9hr_RHb8u1jdu9ouCZ_wn59_kYXY5ni5yHazi_58RRK7q-GsNeWX84Mp5yG_kSWdw1Hb2-yN90vOYV0GMpS57OWo3_If6xwRsR2cKKbvp6bn93VNRVN28050dnzwKdDH1nejOF7yk4O9r_uHcYD4UJcEwpMjB2Vi7whu5R5XagMElkrZSBrcB1XTeqFc8RvZQqvlLaJ9ymWdSqkSowz4hnbbrvWv2Bcy6LW-A0LnriA8yJprDQqbbBqowqI2Pt1t1f1gEZOpBjzqsdRhoo0VJGGIvZ2FD3vIThuEypJd6MAoWaHB93irBqMsDLgIHHa5k5k0tDO2FqfewdK4zbMYKN215qvBlNeVqBw2tPoRYuIvRlfoxHSzYppfbciGQLOQ38gj9jzfqCMLREZbeNkGrF8YwhtNHXzTTv7HoC-tSai-gT7Kgy2f_99VU5LQYWd_xd9ye4DpXKECPRdtn2xWPlX6GBd2NfBkH4DaxsfSQ
  priority: 102
  providerName: Wiley-Blackwell
Title LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbrb3.2466
https://www.ncbi.nlm.nih.gov/pubmed/35025141
https://www.proquest.com/docview/2631889163
https://www.proquest.com/docview/2619544137
https://pubmed.ncbi.nlm.nih.gov/PMC8865150
https://doaj.org/article/a2d20d8b7d354a5499bbe7ed268642a2
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: KQ8
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: Academic Search Ultimate - eBooks
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: ABDBF
  dateStart: 20140501
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: DIK
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: RPM
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: 7X7
  dateStart: 20110901
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: BENPR
  dateStart: 20110901
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: M48
  dateStart: 20110901
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVWIB
  databaseName: KBPluse Wiley Online Library: Open Access
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: AVUZU
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Open Access Journals
  customDbUrl:
  eissn: 2162-3279
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000514240
  issn: 2162-3279
  databaseCode: 24P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELbYJiFeEL_JGJVBPPASNXEcx3lCZOo0IVpNFZPKU-TYDhRVSWnXaeMP4O_mznGzVQxeIitxIjt3Z5_P5-8j5J3mMC7G1oa1USbkjOkwz3UUIvZ5wmVlO-qE8UScnvNPs3TmA25rn1a5HRPdQG1ajTHyIROgfRKcmeTD8meIrFG4u-opNPbIQQyuCmp1Nsv6GAtie8OMtQUUitiwWsHakXGHiXgzDTm0_rtczL8zJW97sG4KOnlEHnrfkX7shP2Y3LPNE3J_7HfHn5Lfn7_iflgq6NIl2dk1nUxZQe2Vz3Zt6OVcUTzK0AViaVtTcPKGx9NRQTGTQ-HhdDpvKLiF9McGBkJoB0WW6euF-tVeXWNRNe2CIos9dTQ6-JH17dS9Z-T8ZPTl-DT0PAuhRvCXkMVIVlOjOfJM5yJlEddCKJbWMH2LOraJMUhrpXIrhKwia2MoyzjhIlJGJc_JftM29iWhkudawjcqZpECOMujuuJKxDW8WoucBeT99reX2oOQIxfGouzgk1mJEipRQgF521dddsgbd1UqUHZ9BQTLdjfa1bfS216pmGGRkVVmkpQrXBBXlc2sYULC6ktBo462ki-9Ba_LG30LyJv-MdgebqioxrYbrIN4eeAGZAF50SlK35IkxdUbjwOS7ajQTlN3nzTz7w7fW0rkp4_gXzll-3fvy2JaJFg4_H8PXpEHDE9tuGTzI7J_sdrY1-BLXVQDssf42cCZzYAcFKPJ2XTg4hJwHXP5B5EBIcI
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkIAXxH8CAwwCiZeoieM4zgNCZGzqWNuHapPKU-bEDutUktKusPIB-Dh8Ru6cpFvF4G1vVuJYdu58vrPPvx8hr3MOdtE3xi200i5nLHfjOPdcxD4PuMxMTZ3QH4juIf80Ckcb5Hd7FwbTKlubaA21rnLcI-8wAdonwZkJ3k-_ucgahaerLYVGrRb7ZvkDQrb5u72PIN83jO3uHGx33YZVwM0R6sRlPlKzFKh8PMpjETKP50IoFhawWInCN4HWSOKkYiOEzDxjfChLP-DCU1oF0O41ch3GyBGrPxpFqz0dxBKHFbIFMPJYJ5tBrMq4xWA8X_YsO8BlLu3fmZkXPWa75O3eIbcbX5V-qJXrLtkw5T1yo9-cxt8nv3qf8fwtFHRqk_rMnA6GLKHmrMmuLen3saJ4daLe-KVVQcGp7GwPdxKKmSMKL8PTcUnBDaUnCzC80A-KrNbLifpZnS2xqMpqQr-CQaOWtgcbmV9MFXxADq9EAg_JZlmV5jGhkse5hDYyZpByOIq9IuNK-AV8WoiYOeRt-9vTvAE9R-6NSVrDNbMUJZSihBzyalV1WiN9XFYpQdmtKiA4t31Qzb6kzVxPFdPM0zKLdBByhQF4lpnIaCYkRHsKOrXVSj5tLMY8Pddvh7xcvYa5jgc4qjTVAusgPh-4HZFDHtWKsupJEGK0yH2HRGsqtNbV9Tfl-NjiiUspwKv14F9ZZfv36NNkmARYePL_EbwgN7sH_V7a2xvsPyW3GN4YsYnuW2TzdLYwz8CPO82e28lDydFVz9Y_7LFXZg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGkCZeEHcCAwwCiZeoie04yQNCZFu1sa1CFZPKk3ESh3UqSWlXWPkB_Ch-Hec4l61i8LY3q3EtJ-fic-zj7yPkZSbAL_rGuEWuc1cwlrlxnHkuYp9zEaWmpk44HMjdI_F-FIzWyO_2LgyWVbY-0TrqvMpwj7zHJGhfBMEM7xVNWcSH7f7b6TcXGaTwpLWl06hVZN8sf0D6Nn-ztw2yfsVYf-fj1q7bMAy4GcKeuMxHmpYCFVGEWSwD5olMSs2CAhYuWfiG5zkSOunYSBmlnjE-tCOfC-npXHMY9xq5HnLBsZwsHIXd_g7iisNq2YIZeayXziBvZcLiMZ4vgZYp4LLw9u8qzYvRs13--rfIzSZupe9qRbtN1kx5h2wcNifzd8mvg094FhdIOrUFfmZOB0OWUHPWVNqW9PtYU7xGUW8C06qgEGD2toY7CcUqEo0X4-m4pBCS0pMFOGGYB0WG6-VE_6zOltjUZTWhX8G5UUvhg4PML5YN3iNHVyKB-2S9rErzkNBIxFkEY6TMIP1wGHtFKrT0C_hrIWPmkNftZ1dZA4COPBwTVUM3M4USUighh7zouk5r1I_LOiUou64DAnXbH6rZF9XYvdIsZ14epWHOA6ExGU9TE5qcyQgyPw2T2mwlrxrvMVfnuu6Q591jsHs8zNGlqRbYB7H6IAQJHfKgVpRuJjzAzFH4DglXVGhlqqtPyvGxxRaPIgkRrgffyirbv99eJcOEY-PR_9_gGdkAO1UHe4P9x-QGw8sjtuZ9k6yfzhbmCYR0p-lTazuUfL5qY_0DJEFboQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LY395756+promotes+NR2B+expression+via+activation+of+AKT%2FCREB+signaling+in+the+juvenile+methylazoxymethanol+mice+model+of+schizophrenia&rft.jtitle=Brain+and+behavior&rft.au=Meng-lin%2C+Li&rft.au=Yuan%2C+Peng&rft.au=An%2C+Ying&rft.au=Guo-yan%2C+Li&rft.date=2022-02-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=2162-3279&rft.volume=12&rft.issue=2&rft_id=info:doi/10.1002%2Fbrb3.2466&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2162-3279&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2162-3279&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2162-3279&client=summon